Elevated vascular endothelial growth factor in systemic sclerosis

Jin Jung Choi, Do June Min, Mi La Cho, So Youn Min, Seon Joon Kim, Shin Seok Lee, Kyung Su Park, Young Il Seo, Wan Uk Kim, Sung Hwan Park, Chul Soo Cho

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

Objective. To determine the serum levels of vascular endothelial growth factor (VEGF) in patients with systemic sclerosis (SSc) and to search for relationships between its serum levels and the clinical manifestations. Methods. Serum levels of VEGF in patients with SSc and healthy controls were determined by ELISA. At the time of blood sampling, individual organ involvement was assessed, and a video microscope and PC based image processing were used to visualize nailfold capillaries and to quantify capillary density. Results. Serum levels of VEGF in 48 patients with SSc were significantly higher than in 30 controls (432 ± 356 vs 91 ± 64 pg/ml; p < 0.001). Patients with diffuse cutaneous SSc (n = 21) had higher levels of serum VEGF than those with limited cutaneous SSc (n = 27) (432 ± 356 vs 135 ± 127 pg/ml; p < 0.001). Serum VEGF levels correlated well with the extent of skin sclerosis, as determined by modified Rodnan skin score (r = 0.656, p < 0.001) and serum TGF-β levels (r = 0.530, p < 0.001). In particular, serum VEGF levels were inversely correlated with the capillary density of nailfold (r = -0.649, p < 0.001). However, no significant differences were found in the serum levels of VEGF between patients with systemic organ involvement and those without. Conclusion. The extent of skin sclerosis may contribute to the elevation of serum VEGF and high VEGF levels may serve as a surrogate indicator of capillary damage in SSc.

Original languageEnglish (US)
Pages (from-to)1529-1533
Number of pages5
JournalJournal of Rheumatology
Volume30
Issue number7
StatePublished - Jul 1 2003

Fingerprint

Systemic Scleroderma
Vascular Endothelial Growth Factor A
Serum
Skin
Sclerosis
Diffuse Scleroderma
Enzyme-Linked Immunosorbent Assay

Keywords

  • Angiogenesis
  • Capillary density
  • Nailfold capillary microscopy
  • Rodnan skin score
  • Systemic sclerosis
  • Vascular endothelial growth factor

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Choi, J. J., Min, D. J., Cho, M. L., Min, S. Y., Kim, S. J., Lee, S. S., ... Cho, C. S. (2003). Elevated vascular endothelial growth factor in systemic sclerosis. Journal of Rheumatology, 30(7), 1529-1533.

Elevated vascular endothelial growth factor in systemic sclerosis. / Choi, Jin Jung; Min, Do June; Cho, Mi La; Min, So Youn; Kim, Seon Joon; Lee, Shin Seok; Park, Kyung Su; Seo, Young Il; Kim, Wan Uk; Park, Sung Hwan; Cho, Chul Soo.

In: Journal of Rheumatology, Vol. 30, No. 7, 01.07.2003, p. 1529-1533.

Research output: Contribution to journalArticle

Choi, JJ, Min, DJ, Cho, ML, Min, SY, Kim, SJ, Lee, SS, Park, KS, Seo, YI, Kim, WU, Park, SH & Cho, CS 2003, 'Elevated vascular endothelial growth factor in systemic sclerosis', Journal of Rheumatology, vol. 30, no. 7, pp. 1529-1533.
Choi JJ, Min DJ, Cho ML, Min SY, Kim SJ, Lee SS et al. Elevated vascular endothelial growth factor in systemic sclerosis. Journal of Rheumatology. 2003 Jul 1;30(7):1529-1533.
Choi, Jin Jung ; Min, Do June ; Cho, Mi La ; Min, So Youn ; Kim, Seon Joon ; Lee, Shin Seok ; Park, Kyung Su ; Seo, Young Il ; Kim, Wan Uk ; Park, Sung Hwan ; Cho, Chul Soo. / Elevated vascular endothelial growth factor in systemic sclerosis. In: Journal of Rheumatology. 2003 ; Vol. 30, No. 7. pp. 1529-1533.
@article{f400ce040a544889bcdfd16059418f13,
title = "Elevated vascular endothelial growth factor in systemic sclerosis",
abstract = "Objective. To determine the serum levels of vascular endothelial growth factor (VEGF) in patients with systemic sclerosis (SSc) and to search for relationships between its serum levels and the clinical manifestations. Methods. Serum levels of VEGF in patients with SSc and healthy controls were determined by ELISA. At the time of blood sampling, individual organ involvement was assessed, and a video microscope and PC based image processing were used to visualize nailfold capillaries and to quantify capillary density. Results. Serum levels of VEGF in 48 patients with SSc were significantly higher than in 30 controls (432 ± 356 vs 91 ± 64 pg/ml; p < 0.001). Patients with diffuse cutaneous SSc (n = 21) had higher levels of serum VEGF than those with limited cutaneous SSc (n = 27) (432 ± 356 vs 135 ± 127 pg/ml; p < 0.001). Serum VEGF levels correlated well with the extent of skin sclerosis, as determined by modified Rodnan skin score (r = 0.656, p < 0.001) and serum TGF-β levels (r = 0.530, p < 0.001). In particular, serum VEGF levels were inversely correlated with the capillary density of nailfold (r = -0.649, p < 0.001). However, no significant differences were found in the serum levels of VEGF between patients with systemic organ involvement and those without. Conclusion. The extent of skin sclerosis may contribute to the elevation of serum VEGF and high VEGF levels may serve as a surrogate indicator of capillary damage in SSc.",
keywords = "Angiogenesis, Capillary density, Nailfold capillary microscopy, Rodnan skin score, Systemic sclerosis, Vascular endothelial growth factor",
author = "Choi, {Jin Jung} and Min, {Do June} and Cho, {Mi La} and Min, {So Youn} and Kim, {Seon Joon} and Lee, {Shin Seok} and Park, {Kyung Su} and Seo, {Young Il} and Kim, {Wan Uk} and Park, {Sung Hwan} and Cho, {Chul Soo}",
year = "2003",
month = "7",
day = "1",
language = "English (US)",
volume = "30",
pages = "1529--1533",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "7",

}

TY - JOUR

T1 - Elevated vascular endothelial growth factor in systemic sclerosis

AU - Choi, Jin Jung

AU - Min, Do June

AU - Cho, Mi La

AU - Min, So Youn

AU - Kim, Seon Joon

AU - Lee, Shin Seok

AU - Park, Kyung Su

AU - Seo, Young Il

AU - Kim, Wan Uk

AU - Park, Sung Hwan

AU - Cho, Chul Soo

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Objective. To determine the serum levels of vascular endothelial growth factor (VEGF) in patients with systemic sclerosis (SSc) and to search for relationships between its serum levels and the clinical manifestations. Methods. Serum levels of VEGF in patients with SSc and healthy controls were determined by ELISA. At the time of blood sampling, individual organ involvement was assessed, and a video microscope and PC based image processing were used to visualize nailfold capillaries and to quantify capillary density. Results. Serum levels of VEGF in 48 patients with SSc were significantly higher than in 30 controls (432 ± 356 vs 91 ± 64 pg/ml; p < 0.001). Patients with diffuse cutaneous SSc (n = 21) had higher levels of serum VEGF than those with limited cutaneous SSc (n = 27) (432 ± 356 vs 135 ± 127 pg/ml; p < 0.001). Serum VEGF levels correlated well with the extent of skin sclerosis, as determined by modified Rodnan skin score (r = 0.656, p < 0.001) and serum TGF-β levels (r = 0.530, p < 0.001). In particular, serum VEGF levels were inversely correlated with the capillary density of nailfold (r = -0.649, p < 0.001). However, no significant differences were found in the serum levels of VEGF between patients with systemic organ involvement and those without. Conclusion. The extent of skin sclerosis may contribute to the elevation of serum VEGF and high VEGF levels may serve as a surrogate indicator of capillary damage in SSc.

AB - Objective. To determine the serum levels of vascular endothelial growth factor (VEGF) in patients with systemic sclerosis (SSc) and to search for relationships between its serum levels and the clinical manifestations. Methods. Serum levels of VEGF in patients with SSc and healthy controls were determined by ELISA. At the time of blood sampling, individual organ involvement was assessed, and a video microscope and PC based image processing were used to visualize nailfold capillaries and to quantify capillary density. Results. Serum levels of VEGF in 48 patients with SSc were significantly higher than in 30 controls (432 ± 356 vs 91 ± 64 pg/ml; p < 0.001). Patients with diffuse cutaneous SSc (n = 21) had higher levels of serum VEGF than those with limited cutaneous SSc (n = 27) (432 ± 356 vs 135 ± 127 pg/ml; p < 0.001). Serum VEGF levels correlated well with the extent of skin sclerosis, as determined by modified Rodnan skin score (r = 0.656, p < 0.001) and serum TGF-β levels (r = 0.530, p < 0.001). In particular, serum VEGF levels were inversely correlated with the capillary density of nailfold (r = -0.649, p < 0.001). However, no significant differences were found in the serum levels of VEGF between patients with systemic organ involvement and those without. Conclusion. The extent of skin sclerosis may contribute to the elevation of serum VEGF and high VEGF levels may serve as a surrogate indicator of capillary damage in SSc.

KW - Angiogenesis

KW - Capillary density

KW - Nailfold capillary microscopy

KW - Rodnan skin score

KW - Systemic sclerosis

KW - Vascular endothelial growth factor

UR - http://www.scopus.com/inward/record.url?scp=0038166874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038166874&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 1529

EP - 1533

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 7

ER -